Distribution of baseline characteristics in the group of patients undergoing radical surgery and palliative chemotherapy (percentages indicated in a vertical column)
| Characteristic | Radical surgery | Palliative chemotherapy only | |
|---|---|---|---|
| Total (n) | 62 | 172 | |
| Age (yr) | 0.272 | ||
| ≤ 50 | 28 (45.2) | 64 (37.2) | |
| > 50 | 34 (54.8) | 108 (62.8) | |
| Sex | 0.021 | ||
| Male | 26 (41.9) | 45 (26.2) | |
| Female | 36 (58.1) | 127 (73.8) | |
| CA19.9 | 0.771 | ||
| >15 U/L | 38 (61.3) | 109 (63.4) | |
| Preoperative biliary drainage | 0.191 | ||
| Yes | 5 (8.1) | 25 (14.5) | |
| Incidental GBC | 18 (29.0) | 86 (50.0) | 0.004 |
| Neoadjuvant chemotherapy | 25 (40.3) | 59 (34.3) | 0.397 |
| Subsite of metastatic disease | < 0.001 | ||
| Station 16 node | 5 (8.1) | 48 (27.9) | |
| Peritoneal | 9 (14.5) | 97 (56.4) | |
| Liver | 2 (3.2) | 17 (9.9) | |
| N2 disease | 46 (74.2) | 0 (0.0) | |
| Port/Scar site | 0 (0.0) | 10 (5.8) | |
| Grade | 0.084 | ||
| Well differentiated | 7 (11.3) | 28 (16.3) | |
| Moderately differentiated | 33 (53.2) | 61 (35.5) | |
| Poorly differentiated | 22 (35.5) | 83 (48.2) |
Values are presented as number (%).
GBC, gallbladder cancer.